Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

NCT04574999 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Vaginal Atrophy

Interventions

DRUG: Estriol
OTHER: Placebo

Sponsor

Italfarmaco S.A